Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Go back to Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics| (NASDAQ: ANAB) | Delayed: 53.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.92 | 52 Week High | $ | |||
| Open | $53.92 | 52 Week Low | $ | |||
| Day High | $53.92 | P/E | N/A | |||
| Day Low | $53.92 | EPS | $ | |||
| Volume | 306 | |||||
